The Service of the Commission for the Protection of Competition announces that CVC Capital Partners SICAV-FIS S.A., has notified the Commission for the Protection of Competition, that it intends to proceed with the acquisition of the share capital of WSHP Intermediate Holding S.ΰ r.l., through Sebia S.A..
Sebia is a company duly registered under the laws of France, which is indirectly controlled by CVC Capital Partners SICAV-FIS S.A., through certain CVC Funds. Sebia designs, manufactures and sells in vitro diagnostic ("IVD") test instruments and reagents (in vitro diagnostic testing instruments and reagents). More specifically, Sebia mainly offers instruments and clinical chemistry reagents.
CVC Capital Partners SICAV-FIS S.A. is a company duly registered in accordance with the laws of Luxembourg which, together with its subsidiaries and affiliates, constitute the "CVC Network". The activities of these companies include the provision of investment advice and/or investment management by certain investment funds and platforms (the 'CVC Funds'). The CVC Funds hold stakes in a number of companies in various industries, including companies dealing with chemicals, utilities, service delivery, manufacturing, retail and distribution.